Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)

Carcinoma of Unknown Primary (CUP) is a heterogeneous and metastatic disease where the primary site of origin is undetectable. Currently, chemotherapy is the only state-of-art treatment option for CUP patients. The molecular profiling of the tumour, particularly mutation detection, offers a new trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Es, Hamidreza Aboulkheyr, Mahdizadeh, Hamid, Asl, Amir Abbas Hedayati, Totonchi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302572/
https://www.ncbi.nlm.nih.gov/pubmed/34302033
http://dx.doi.org/10.1038/s41598-021-94678-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302572/
https://www.ncbi.nlm.nih.gov/pubmed/34302033
http://dx.doi.org/10.1038/s41598-021-94678-4

Ejemplares similares